EQUILLIUM, INC. Earnings Per Share (Basic)
EQUILLIUM, INC. (EQ) reported Earnings Per Share (Basic) of -$0.04 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- EQUILLIUM, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.04.
- EQUILLIUM, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.06.
- EQUILLIUM, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.04.
- EQUILLIUM, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.06.
- EQUILLIUM, INC. earnings per share, basic for fiscal 2025 was -$0.39.
- EQUILLIUM, INC. earnings per share, basic for fiscal 2024 was -$0.23.
- EQUILLIUM, INC. earnings per share, basic for fiscal 2023 was -$0.38.
- EQUILLIUM, INC. earnings per share, basic for fiscal 2022 was -$1.85.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.04 10-Q · filed 2026-08-13 | -$0.10 10-Q · filed 2026-08-13 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2026-03-31 | -$0.06 10-Q · filed 2026-05-13 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-12-31 | -$0.04 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.10 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.21 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.39 10-K · filed 2026-03-25 |
| 2025-09-30 | -$0.06 10-Q · filed 2025-11-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.41 10-Q · filed 2025-11-13 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-06-30 | -$0.16 10-Q · filed 2026-08-13 | -$0.40 10-Q · filed 2026-08-13 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.57 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2025-03-31 | -$0.24 10-Q · filed 2026-05-13 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.39 derived: net income ÷ weighted average shares · filed 2026-08-13 |
| 2024-12-31 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.16 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.15 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.23 10-K · filed 2026-03-25 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.01 derived: net income ÷ weighted average shares · filed 2025-11-13 | -$0.06 10-Q · filed 2025-11-13 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2024-06-30 | $0.01 10-Q · filed 2025-08-14 | -$0.06 10-Q · filed 2025-08-14 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2024-03-31 | -$0.08 10-Q · filed 2025-05-14 | -$0.14 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.25 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-04-15 |
| 2023-12-31 | -$0.07 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.27 derived: net income ÷ weighted average shares · filed 2026-04-15 | -$0.38 10-K · filed 2025-03-27 |
| 2023-09-30 | -$0.11 10-Q · filed 2024-11-13 | -$0.20 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.32 10-Q · filed 2024-11-13 | -$0.24 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-06-30 | -$0.10 10-Q · filed 2024-08-08 | -$0.21 10-Q · filed 2024-08-08 | -$0.13 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2023-03-31 | -$0.11 10-Q · filed 2024-05-09 | -$0.03 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.43 derived: net income ÷ weighted average shares · filed 2024-11-13 | -$0.84 derived: net income ÷ weighted average shares · filed 2024-11-13 |
| 2022-12-31 | $0.08 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$0.32 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$0.73 derived: net income ÷ weighted average shares · filed 2024-03-25 | -$1.85 10-K · filed 2024-03-25 |
| 2022-09-30 | -$0.40 10-Q · filed 2023-11-08 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.95 10-Q · filed 2023-11-08 | -$2.33 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2022-06-30 | -$0.41 10-Q · filed 2023-08-09 | -$1.56 10-Q · filed 2023-08-09 | -$1.95 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.32 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2022-03-31 | -$1.17 10-Q · filed 2023-05-11 | -$1.57 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$1.93 derived: net income ÷ weighted average shares · filed 2023-11-08 | -$2.25 derived: net income ÷ weighted average shares · filed 2023-11-08 |
| 2021-12-31 | -$0.36 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$0.71 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.03 derived: net income ÷ weighted average shares · filed 2023-03-23 | -$1.36 10-K · filed 2023-03-23 |
| 2021-09-30 | -$0.35 10-Q · filed 2022-11-14 | -$0.67 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.99 10-Q · filed 2022-11-14 | |
| 2021-06-30 | -$0.31 10-Q · filed 2022-08-15 | -$0.64 10-Q · filed 2022-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |